However, corroborating previous findings of a beneficial effect of ghrelin signaling against the aging process (26, 80), an alternative interpretation of the results is that the exacerbation of abnormal LEAP2 levels, if left untreated, may worsen hippocampal aging and the age-related cognitive decline, eventually leading to severe consequences such as AD. Here, LEAP2 is linked to Alzheimer disease.